Tissue Regenix Group Plc (TRX) — Capital Reinvestment Ratio
Latest as of December 2023:
0.11x
Tissue Regenix Group Plc (TRX) has a Capital Reinvestment Ratio of 0.11x as of December 2023, meaning it reinvests 0% of its operating cash flow (GBX1.36 Million) in capital expenditures (GBX153.75K). See cash generation quality of Tissue Regenix Group Plc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.11x
Capex / Operating Cash Flow
Operating Cash Flow
GBX1.36 Million
GBX
Capital Expenditures
GBX153.75K
GBX
Data as of
Dec 2023
Most recent filing
Tissue Regenix Group Plc Capital Reinvestment Ratio (2023–2023)
This chart tracks Tissue Regenix Group Plc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Tissue Regenix Group Plc (2023–2023)
Year-by-year Capital Reinvestment Ratio for Tissue Regenix Group Plc from 2023 to 2023. For live market cap and broader valuation context, see market value of Tissue Regenix Group Plc.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.83x | GBX1.04 Million | GBX863.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow